Why the study?
Altered cardiac repolarisation is linked to ventricular fibrillation and MACE after acute myocardial infarction, and treating sleep disordered breathing may normalise the ventricular ectopic substrate.
Does early adaptive servoventilation improve cardiac repolarisation in patients with acute myocardial infarction and sleep disordered breathing?
Does early adaptive servoventilation improve cardiac repolarisation in patients with acute myocardial infarction and sleep disordered breathing?
Early adaptive servoventilation in patients with acute MI and sleep disordered breathing transiently improves cardiac repolarisation at 4 weeks, which may help prevent early ventricular arrhythmias.
Supports early ASV to shorten QTc and potentially lower arrhythmic risk post-MI with SDB; extends RCT evidence on repolarization effects.
Background In patients with acute myocardial infarction, altered cardiac repolarisation has been linked to ventricular fibrillation and major adverse cardiac events. Treatment of sleep disordered breathing early after acute myocardial infarction may normalise the ventricular ectopic substrate. Therefore, the aim of this ancillary analysis was to assess the effect of adaptive servoventilation (ASV) on cardiac repolarisation. Methods This analysis included 42 participants from the prospective multicentre randomised trial TEAM-ASV I. 22 were randomised to early treatment with ASV in addition to standard care, and 20 to standard care only. Cardiac repolarisation was assessed by means of T-peak-to-end- (TpTe c ) and QT c - intervals and TpTe/QT-ratios derived from 12-lead ECG before and 4 and 12 weeks after percutaneous coronary intervention. Results The population was predominantly male (79%), obese (mean± sd body mass index 31±6 kg·m −2 ), had severe sleep disordered breathing with an apnoea–hypopnoea index of 34±18 events·h −1 and ASV was initiated within 2.6±1 days. After 4 weeks, QT c significantly decreased in the ASV group compared to the control group (−5.8% versus −1.2%, p=0.041). A similar trend was observed with respect to TpTe c (−18.0% versus −6.8%, p=0.119) and TpTe/QT (−17.6% versus −6.6%, p=0.252). After 12 weeks, the decrease in repolarisation times was similar between the groups. (QT c −7.6% versus −4.5%, p=0.400; TpTe c −19.3% versus −18.8%, p=0.400; TpTe/QT −9.7 versus −13.0, p=0.652). Conclusion In patients with first acute myocardial infarction and sleep disordered breathing, early treatment with ASV reduced cardiac repolarisation after 4 weeks, but not after 12 weeks. Thus, ASV may contribute to preventing ventricular arrhythmias in the vulnerable early phase after acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Kohn et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: